Benitec Biopharma Inc. (NASDAQ: BNTC) reported Q2 EPS of ($0.20), $0.09 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Benitec Biopharma Inc. (BNTC) click here.